- 川宁生物 (301301)- 净利润 之 形成过程

利润分析步骤二:分析 营业利润 到 净利润 的变化

营业利润

12.9亿    ,3.9,1.2,2.8,2.2,5.5,11.2,12.9
了解明细
营业外收入

0.0亿    ,0.0,0.0,0.0,0.0,0.0,0.0,0.0
了解明细
营业外支出

0.2亿    ,0.0,0.1,0.0,0.9,0.6,0.1,0.2
了解明细
利润总额

12.8亿    ,3.9,1.1,2.8,1.3,4.9,11.2,12.8
了解明细


净利润

10.8亿    ,3.9,0.9,2.3,1.1,4.1,9.4,10.8
了解明细
所得税

2.0亿    ,-0.0,0.2,0.5,0.2,0.8,1.8,2.0
了解明细


归母净利润

10.8亿    ,3.9,0.9,2.3,1.1,4.1,9.4,10.8
了解明细
少数股东损益

0.0亿    ,0.0,-0.0,0.0,0.0,-0.0,0.0,0.0
了解明细
持续经营净利润

10.8亿    ,3.9,0.9,2.3,1.1,4.1,9.4,10.8
了解明细
终止经营净利润

0亿    ,0,0,0,0,0,0,0
了解明细


归母其他综合收益

0亿    ,0,0,0,0,0,0,0
了解明细
归少数股东其他综合收益

0亿    ,0,0,0,0,0,0,0
了解明细


归母综合收益总额

10.8亿    ,3.9,0.9,2.3,1.1,4.1,9.4,10.8
了解明细
归少数股东综合收益总额

0.0亿    ,0.0,-0.0,0.0,0.0,-0.0,0.0,0.0
了解明细